A Protective Role of Glibenclamide in Inflammation-Associated Injury

Glibenclamide is the most widely used sulfonylurea drug for the treatment of type 2 diabetes mellitus (DM). Recent studies have suggested that glibenclamide reduced adverse neuroinflammation and improved behavioral outcomes following central nervous system (CNS) injury. We reviewed glibenclamide...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Gensheng, Lin, Xiuhui, Zhang, Shufang, Xiu, Huiqing, Pan, Chuli, Cui, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504948/
https://www.ncbi.nlm.nih.gov/pubmed/28740332
http://dx.doi.org/10.1155/2017/3578702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504948/
https://www.ncbi.nlm.nih.gov/pubmed/28740332
http://dx.doi.org/10.1155/2017/3578702

Ejemplares similares